For press inquiries, please contact us using the form below.
Cohen Veterans Bioscience is the only 501(c)3 non-profit research organization with a singular focus on PTSD and TBI research. We are dedicated to fast-tracking the development of diagnostic tests and personalized medicines for the millions of veterans and civilians who suffer the devastating effects of trauma on the brain.
Resources & Documents
- Cohen Veterans Bioscience Fact Sheet
- Cohen Veterans Bioscience Digital Press Kit
- Cohen Veterans Bioscience Programs
- PTSD & TBI Fact Sheet
Follow Cohen Veterans Bioscience
Cohen Veterans Bioscience and American College Of Radiology Launch First of Its Kind Imaging Library for Traumatic Brain InjuryRead more
Cohen Veterans Bioscience and the American College of Radiology (ACR) today announced the creation of the first Traumatic Brain Injury (TBI) Imaging Reference Library. The library will be essential to the development of effective clinical imaging tools for diagnosing and managing patients with mild TBI.
Cohen Veterans Bioscience and the Broad Institute’s Stanley Center for Psychiatric Research with PTSD researchers from the Psychiatric Genomics Consortium Announce Initial Findings from Largest Study of Genetic Markers for Post-Traumatic Stress DisorderRead more
Cohen Veterans Bioscience and the Stanley Center for Psychiatric Research today marked an important milestone towards the discovery of the first population genome-wide significant markers of post-traumatic stress disorder (PTSD) risk.
Cohen Veterans Bioscience and the Veterans Health Administration Announce Landmark Partnership to Advance the Diagnosis and Treatment of Trauma-related Brain DisordersRead more
Cohen Veterans Bioscience and the U.S. Department of Veterans Affairs (VA) today announced a new public-private partnership for Biomarkers & Diagnostics for trauma-related brain disorders at the VA’s second annual Brain Trust: Pathways to InnoVAtion event in Boston.
- Read more
A new collaboration between Cohen Veterans Bioscience and Stanford University School of Medicine announced today, seeks to change this by studying clinical biomarkers as a way to help match patients to the best available treatment.
CDISC and Cohen Veterans Bioscience Partner to Establish the First Therapeutic Area Standard for PTSDRead more
The Clinical Data Interchange Standards Consortium (CDISC) and Cohen Veterans Bioscience today announced a collaboration to establish a new CDISC Therapeutic Area Data Standard for post- traumatic stress disorder (PTSD).